SEC Form 4 · accession 0001127602-15-007419
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas DesRosier
Officer — EVP, General Counsel
Period of report
Feb 18, 2015
Accepted (ET)
Feb 20, 2015 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Feb 18, 2015 | A | 110,000 | A | — | — | Common Stock | 110,000 | 110,000 | D |
| Employee Stock Option (Right to Buy)F3 | $7.34 | Feb 18, 2015 | A | 130,000 | A | — | Feb 18, 2025 | Common Stock | 130,000 | 130,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- F2Restricted stock units vest 50% per year on each February 18 of 2016 and 2017.
- F3Options vest 25% per year on each February 18 of 2016, 2017, 2018 and 2019.